Form 4: PROCEPT BioRobotics Exec Nouri Acquires Shares

Sentiment:

Insider Transaction Report


PROCEPT BioRobotics EVP, CLO, and Corporate Secretary Alaleh Nouri acquired 4,872 shares of common stock through the vesting of performance stock units.

Summary

  • Alaleh Nouri, Executive Vice President, Chief Legal Officer, and Corporate Secretary of PROCEPT BioRobotics Corp (PRCT), acquired 4,872 shares of common stock.
  • The acquisition resulted from the vesting of a portion of previously granted performance stock units (PSUs).
  • The vesting was triggered by the Issuer's Compensation Committee certifying the achievement of certain pre-determined performance criteria on February 19, 2026.
  • Each PSU represents a contingent right to receive one share of the Issuer's common stock.
  • Following this transaction, Alaleh Nouri beneficially owns a total of 77,345 shares of common stock.
  • The acquired shares are scheduled to vest on March 5, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, indicating the company met performance targets for executive compensation, which is a routine and generally favorable outcome.

Positives

  • The company successfully achieved pre-determined performance criteria, leading to the vesting of executive performance stock units.

Future Outlook

The acquired shares, representing earned performance stock units, are scheduled to vest on March 5, 2026.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to compensation vesting, are common occurrences in publicly traded companies. This event provides insight into executive compensation structures and the achievement of internal performance targets within the medical robotics and device industry.

Related Party Transactions

  • The acquisition of shares by an executive through the vesting of performance stock units is a form of related-party transaction, representing executive compensation.

Stakeholder Impact

  • Shareholders: Increased executive ownership aligns management's interests with those of shareholders.
  • Employees: Reflects the successful achievement of company performance goals, which can positively impact morale and future incentive programs.

Next Steps

  • The 4,872 shares of common stock underlying the performance stock units will vest on March 5, 2026.

Key Dates

DateDescription
02/19/2026Performance criteria for performance stock units (PSUs) were certified by the Issuer's Compensation Committee, deeming the units earned.
02/25/2026Date the Form 4 filing was signed and submitted.
03/05/2026Date when the shares underlying the earned performance stock units will vest.

Recommendation

hold

This Form 4 reports a routine vesting of performance stock units for an executive, indicating the achievement of pre-determined company performance criteria. While positive, it is a standard compensation event and does not provide sufficient new information to alter a broader investment thesis, thus a 'hold' recommendation is appropriate for this specific filing.

Keywords

PROCEPT BioRobotics, PRCT, Alaleh Nouri, Form 4, Insider Trading, Performance Stock Units, PSUs, Stock Vesting, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.